Wegovy, Ozempic and Research Semaglutide — What Irish Researchers Should Understand (2026)

By the Peptides Lab Ireland research team · Updated July 2026 · Research reference

Wegovy, Ozempic and research-grade Semaglutide are three names attached to the same active ingredient but they represent three completely different regulatory categories. Confusing them is the single most common misunderstanding in the current peptide research space. This explainer is for Irish researchers, procurement officers and journalists who want the distinction to be crystal clear.

The active ingredient is the same. The category isn’t.

All three products contain Semaglutide : a GLP-1 receptor agonist peptide. What differs:

• Wegovy — Novo Nordisk’s brand name for Semaglutide licensed as a chronic weight-management medicine. Prescription-only medicinal product in Ireland and the EU. Higher dose formulation than Ozempic.
• Ozempic , with Novo Nordisk’s brand name for Semaglutide licensed as a type 2 diabetes medicine. Prescription-only. Different dose titration schedule to Wegovy.
• Research-grade Semaglutide : The Semaglutide peptide supplied in lyophilised research-grade form for in-vitro laboratory research. Not a medicinal product. Not for human use. Regulated under research chemical, not medicines, frameworks.

Why this matters legally

Wegovy and Ozempic are medicinal products authorised by the European Medicines Agency (EMA) and regulated in Ireland by the Health Products Regulatory Authority (HPRA). They can only be dispensed via a licensed prescription.

Research-grade Semaglutide is not a medicinal product. It is a research chemical supplied for in-vitro laboratory research. Any supplier presenting research-grade Semaglutide as a substitute for Wegovy or Ozempic , or providing dosing guidance for human use and is misrepresenting the product and creating regulatory exposure for both themselves and their customers.

See our HPRA regulations guide for the full detail on this distinction.

Why researchers use research-grade Semaglutide

Research-grade Semaglutide is a legitimate research reagent used in:

• Cell-culture receptor pharmacology studies (GLP-1R activation, β-cell signalling)
• Animal-model metabolic research (rodent glucose homeostasis, feeding behaviour)
• Comparative studies against Tirzepatide, Retatrutide and other GLP-1-class compounds
• Preclinical translational research (cardiovascular, neuroprotection, appetite biology)

For this research use, HPLC-verified purity with per-batch Certificate of Analysis is the industry standard. This is what Peptides Lab Ireland supplies.

What research-grade Semaglutide is NOT

• Not a cheap substitute for prescription Wegovy or Ozempic
• Not intended for human use under any circumstances
• Not formulated for human injection (no sterility validation for parenteral human use, no clinical trials, no medicines regulator authorisation)
• Not covered by medicines regulatory quality frameworks — it’s a research chemical, verified analytically for research purposes

What’s the same and what’s different — a summary table

The regulatory line and and why Peptides Lab Ireland holds it clearly

Suppliers who position research-grade Semaglutide as a Wegovy or Ozempic substitute , or who provide dosing schedules aimed at humans , are creating a compliance problem that HPRA is actively enforcing against. Peptides Lab Ireland holds a strict research-only supply model:

• Product pages describe research applications, not therapeutic effects
• No before/after imagery, no human dosing schedules, no treatment claims
• Every vial labelled “For laboratory research use only , not for human or veterinary use”
• Batch-specific Certificate of Analysis with every order
• Customs paperwork accurately describes research chemicals for research use

Further reading

• Semaglutide Ireland — Research Reference
• Semaglutide Dosage Chart , Research Reference
• HPRA and Research Peptides in Ireland
• How to Buy Research Peptides in Ireland (2026 Guide)

This article is research-context information, not medical advice. If you’re considering a prescription weight-management or diabetes medicine, speak with a licensed medical professional in Ireland. Research-grade Semaglutide supplied by Peptides Lab Ireland is for in-vitro laboratory research and educational use only — not intended for human or veterinary use.